The impact of enhanced recovery after surgery (ERAS) on opioid consumption after cesarean delivery

Completed

• Conditions: patient undergo cesarean delivery; enhanced recovery after surgery; ERAS; cesarean delivery; opioid consumption

• Registration Number: TCTR20221029003
• Lead Sponsor: niversity of Phayao

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-11-26
• Study Start: 2022-10-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

1. Pregnant patients undergo cesarean delivery,
2. ASA physical status 1-3,
3. History of opioid dependence,
4. History of chronic pain
5. History of allergy to opioids, ketorolac, paracetamol, ibuprofen,
6. History of asthma

Exclusion Criteria

1. Body Mass Index more than 35.0 kg/m2,
2. Obstetric life-threatening conditions,

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Opioid consumption 24 hours post-operatively and total consumption milligram-morphine equivalents

Secondary Outcome Measures

Name	Time	Method
post-operative pain score at 1, 24 and 48 hours Patient reported outcome using a verbal numerical rating score,Hospital length of stay after operation until discharge from hospital review medical record,Maternal and neonatal complications after operation until discharge from hospital review medical record